Strain identifier
BacDive ID: 147820
Type strain:
Species: Lacticaseibacillus rhamnosus
NCBI tax ID(s): 47715 (species)
version 8.1 (current version)
General
@ref: 52036
BacDive-ID: 147820
keywords: genome sequence, Bacteria, aerobe, mesophilic
description: Lacticaseibacillus rhamnosus CCUG 34291 is an aerobe, mesophilic bacterium that was isolated from Human feces.
NCBI tax id
- NCBI tax id: 47715
- Matching level: species
doi: 10.13145/bacdive147820.20230509.8.1
Name and taxonomic classification
LPSN
- @ref: 20215
- description: domain/bacteria
- keyword: phylum/bacillota
- domain: Bacteria
- phylum: Bacillota
- class: Bacilli
- order: Lactobacillales
- family: Lactobacillaceae
- genus: Lacticaseibacillus
- species: Lacticaseibacillus rhamnosus
- full scientific name: Lacticaseibacillus rhamnosus (Hansen 1968) Zheng et al. 2020
synonyms
@ref synonym 20215 Lactobacillus casei subsp. rhamnosus 20215 Lactobacillus rhamnosus
@ref: 52036
domain: Bacteria
phylum: Firmicutes
class: Bacilli
order: Lactobacillales
family: Lactobacillaceae
genus: Lactobacillus
species: Lactobacillus rhamnosus
type strain: no
Morphology
cell morphology
@ref | motility | confidence | gram stain |
---|---|---|---|
69480 | no | 97.167 | |
69480 | 100 | positive |
Culture and growth conditions
culture temp
- @ref: 52036
- growth: positive
- type: growth
- temperature: 37
- range: mesophilic
Physiology and metabolism
oxygen tolerance
- @ref: 52036
- oxygen tolerance: aerobe
spore formation
@ref | spore formation | confidence |
---|---|---|
69480 | no | 99.945 |
69481 | no | 100 |
metabolite utilization
@ref | metabolite | utilization activity | kind of utilization tested | Chebi-ID |
---|---|---|---|---|
68371 | Potassium 5-ketogluconate | - | builds acid from | |
68371 | Potassium 2-ketogluconate | - | builds acid from | |
68371 | gluconate | - | builds acid from | 24265 |
68371 | L-arabitol | - | builds acid from | 18403 |
68371 | D-arabitol | - | builds acid from | 18333 |
68371 | L-fucose | + | builds acid from | 18287 |
68371 | D-fucose | - | builds acid from | 28847 |
68371 | D-tagatose | + | builds acid from | 16443 |
68371 | D-lyxose | - | builds acid from | 62318 |
68371 | turanose | - | builds acid from | 32528 |
68371 | gentiobiose | + | builds acid from | 28066 |
68371 | xylitol | - | builds acid from | 17151 |
68371 | glycogen | - | builds acid from | 28087 |
68371 | starch | - | builds acid from | 28017 |
68371 | raffinose | - | builds acid from | 16634 |
68371 | melezitose | + | builds acid from | 6731 |
68371 | inulin | - | builds acid from | 15443 |
68371 | trehalose | + | builds acid from | 27082 |
68371 | sucrose | - | builds acid from | 17992 |
68371 | melibiose | - | builds acid from | 28053 |
68371 | lactose | - | builds acid from | 17716 |
68371 | maltose | - | builds acid from | 17306 |
68371 | cellobiose | + | builds acid from | 17057 |
68371 | salicin | + | builds acid from | 17814 |
68371 | esculin | + | builds acid from | 4853 |
68371 | arbutin | + | builds acid from | 18305 |
68371 | amygdalin | + | builds acid from | 27613 |
68371 | N-acetylglucosamine | + | builds acid from | 59640 |
68371 | methyl alpha-D-glucopyranoside | - | builds acid from | 320061 |
68371 | methyl alpha-D-mannoside | - | builds acid from | 43943 |
68371 | D-sorbitol | + | builds acid from | 17924 |
68371 | D-mannitol | + | builds acid from | 16899 |
68371 | myo-inositol | + | builds acid from | 17268 |
68371 | galactitol | + | builds acid from | 16813 |
68371 | L-rhamnose | + | builds acid from | 62345 |
68371 | L-sorbose | - | builds acid from | 17266 |
68371 | D-mannose | + | builds acid from | 16024 |
68371 | D-fructose | + | builds acid from | 15824 |
68371 | D-glucose | + | builds acid from | 17634 |
68371 | D-galactose | + | builds acid from | 12936 |
68371 | methyl beta-D-xylopyranoside | - | builds acid from | 74863 |
68371 | ribitol | - | builds acid from | 15963 |
68371 | L-xylose | - | builds acid from | 65328 |
68371 | D-xylose | - | builds acid from | 65327 |
68371 | D-ribose | + | builds acid from | 16988 |
68371 | L-arabinose | - | builds acid from | 30849 |
68371 | D-arabinose | + | builds acid from | 17108 |
68371 | erythritol | - | builds acid from | 17113 |
68371 | glycerol | - | builds acid from | 17754 |
68381 | arginine | - | hydrolysis | 29016 |
68381 | D-ribose | - | builds acid from | 16988 |
68381 | D-mannitol | + | builds acid from | 16899 |
68381 | sorbitol | - | builds acid from | 30911 |
68381 | lactose | - | builds acid from | 17716 |
68381 | trehalose | + | builds acid from | 27082 |
68381 | raffinose | - | builds acid from | 16634 |
68381 | sucrose | - | builds acid from | 17992 |
68381 | L-arabinose | - | builds acid from | 30849 |
68381 | D-arabitol | - | builds acid from | 18333 |
68381 | alpha-cyclodextrin | - | builds acid from | 40585 |
68381 | hippurate | + | hydrolysis | 606565 |
68381 | glycogen | - | builds acid from | 28087 |
68381 | pullulan | - | builds acid from | 27941 |
68381 | maltose | - | builds acid from | 17306 |
68381 | melibiose | - | builds acid from | 28053 |
68381 | melezitose | - | builds acid from | 6731 |
68381 | methyl beta-D-glucopyranoside | - | builds acid from | 320055 |
68381 | D-tagatose | + | builds acid from | 16443 |
68381 | urea | - | hydrolysis | 16199 |
metabolite production
- @ref: 68381
- Chebi-ID: 15688
- metabolite: acetoin
- production: yes
metabolite tests
- @ref: 68381
- Chebi-ID: 15688
- metabolite: acetoin
- voges-proskauer-test: +
enzymes
@ref | value | activity | ec |
---|---|---|---|
68381 | urease | - | 3.5.1.5 |
68381 | beta-mannosidase | - | 3.2.1.25 |
68381 | glycyl tryptophan arylamidase | - | |
68381 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 |
68381 | pyrrolidonyl arylamidase | + | 3.4.19.3 |
68381 | beta-galactosidase | + | 3.2.1.23 |
68381 | Alanyl-Phenylalanyl-Proline arylamidase | + | |
68381 | alkaline phosphatase | - | 3.1.3.1 |
68381 | alpha-galactosidase | - | 3.2.1.22 |
68381 | beta-glucuronidase | - | 3.2.1.31 |
68381 | beta-glucosidase | + | 3.2.1.21 |
68381 | arginine dihydrolase | - | 3.5.3.6 |
API 50CHac
@ref | Q | GLY | ERY | DARA | LARA | RIB | DXYL | LXYL | ADO | MDX | GAL | GLU | FRU | MNE | SBE | RHA | DUL | INO | MAN | SOR | MDM | MDG | NAG | AMY | ARB | ESC | SAL | CEL | MAL | LAC | MEL | SAC | TRE | INU | MLZ | RAF | AMD | GLYG | XLT | GEN | TUR | LYX | TAG | DFUC | LFUC | DARL | LARL | GNT | 2KG | 5KG |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
52036 | - | - | - | + | - | + | - | - | - | - | + | + | + | + | - | + | + | + | + | + | - | - | + | + | + | + | + | + | - | - | - | - | + | - | + | - | - | - | - | + | - | - | + | - | + | - | - | - | - | - |
API rID32STR
@ref | ADH Arg | beta GLU | beta GAR | beta GUR | alpha GAL | PAL | RIB | MAN | SOR | LAC | TRE | RAF | SAC | LARA | DARL | CDEX | VP | APPA | beta GAL | PyrA | beta NAG | GTA | HIP | GLYG | PUL | MAL | MEL | MLZ | Mbeta DG | TAG | beta MAN | URE |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
52036 | - | + | + | - | - | - | - | + | - | - | + | - | - | - | - | - | + | + | + | + | - | - | + | - | - | - | - | - | - | + | - | - |
Isolation, sampling and environmental information
isolation
- @ref: 52036
- sample type: Human feces
isolation source categories
Cat1 | Cat2 | Cat3 |
---|---|---|
#Host | #Human | |
#Host Body Product | #Gastrointestinal tract | #Feces (Stool) |
Sequence information
Genome sequences
@ref | description | accession | assembly level | database | NCBI tax ID |
---|---|---|---|---|---|
66792 | Lacticaseibacillus rhamnosus GG GG (ATCC 53103) | GCA_000026505 | complete | ncbi | 568703 |
66792 | Lacticaseibacillus rhamnosus GG ATCC 53103 | GCA_000011045 | complete | ncbi | 568703 |
66792 | Lactobacillus rhamnosus GG ATCC 53103 | 568703.30 | complete | patric | 568703 |
Genome-based predictions
predictions
trait | prediction | confidence | training_data |
---|---|---|---|
spore-forming | no | 100 | no |
motile | no | 93.874 | no |
flagellated | no | 97.66 | no |
gram-positive | yes | 93.955 | no |
anaerobic | no | 94.765 | no |
aerobic | no | 94.303 | yes |
halophile | yes | 80.377 | no |
spore-forming | no | 90.694 | no |
glucose-util | yes | 92.014 | no |
thermophile | no | 97.61 | yes |
glucose-ferment | yes | 89.102 | no |
External links
@ref: 52036
culture collection no.: CCUG 34291, ATCC 53103, LMG 18243
straininfo link
- @ref: 102489
- straininfo: 8915
literature
topic | Pubmed-ID | title | authors | journal | DOI | year | mesh | topic2 |
---|---|---|---|---|---|---|---|---|
Metabolism | 7552958 | Effect of Lactobacillus rhamnosus strain GG (ATCC 53103) on the growth of Streptococcus sobrinus in vitro. | Meurman JH, Antila H, Korhonen A, Salminen S | Eur J Oral Sci | 10.1111/j.1600-0722.1995.tb00169.x | 1995 | *Antibiosis, Ecology, Enterococcus faecalis/growth & development/metabolism/ultrastructure, Fermentation, Humans, Hydrogen-Ion Concentration, Lactobacillus/chemistry/classification/metabolism/*physiology, Lactobacillus casei/chemistry/classification/metabolism/physiology, Mouth/microbiology, Streptococcus sanguis/growth & development/metabolism/ultrastructure, Streptococcus sobrinus/*growth & development/metabolism/ultrastructure, Sucrose/metabolism | Pathogenicity |
Pathogenicity | 9172443 | Recovery of Lactobacillus rhamnosus GG from human colonic biopsies. | Alander M, Korpela R, Saxelin M, Vilpponen-Salmela T, Mattila-Sandholm T, von Wright A | Lett Appl Microbiol | 10.1046/j.1472-765x.1997.00140.x | 1997 | Adult, Aged, Animals, Bacterial Adhesion, Colon/*microbiology, Colonoscopy, Ecosystem, Feces/microbiology, Female, Humans, Lactobacillus/growth & development/*isolation & purification, Male, Middle Aged, Milk/microbiology | Enzymology |
Pathogenicity | 9237125 | Lactobacillus rhamnosus GG (ATCC 53103) and platelet aggregation in vitro. | Korpela R, Moilanen E, Saxelin M, Vapaatalo H | Int J Food Microbiol | 10.1016/s0168-1605(97)00049-4 | 1997 | Adult, Humans, Lactobacillus/*pathogenicity, Middle Aged, *Platelet Aggregation | |
Phylogeny | 9706787 | Vancomycin resistance factor of Lactobacillus rhamnosus GG in relation to enterococcal vancomycin resistance (van) genes. | Tynkkynen S, Singh KV, Varmanen P | Int J Food Microbiol | 10.1016/s0168-1605(98)00051-8 | 1998 | Anti-Bacterial Agents/pharmacology, Conjugation, Genetic, DNA, Bacterial/genetics, Drug Resistance, Microbial/genetics, Enterococcus faecalis/*genetics, Enterococcus faecium/*genetics, Genes, Bacterial/*genetics, Lactobacillus/*genetics, Nucleic Acid Hybridization/methods, Polymerase Chain Reaction/methods, Vancomycin/pharmacology | |
Pathogenicity | 11122221 | Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. | Pessi T, Sutas Y, Hurme M, Isolauri E | Clin Exp Allergy | 10.1046/j.1365-2222.2000.00948.x | 2000 | Animals, Child, Preschool, Dermatitis, Atopic/blood/etiology/*therapy, Edible Grain/adverse effects, Eggs/adverse effects, Feces/chemistry, Food Hypersensitivity/blood/etiology/*therapy, Humans, Immunoglobulin A/analysis, Infant, Interleukin-10/analysis/*biosynthesis/blood, *Lactobacillus, Leukocytes, Mononuclear/immunology, Milk/adverse effects, Probiotics/*therapeutic use, Tumor Necrosis Factor-alpha/analysis | |
Pathogenicity | 11360922 | Suppression of T-cell activation by Lactobacillus rhamnosus GG-degraded bovine casein. | Pessi T, Isolauri E, Sutas Y, Kankaanranta H, Moilanen E, Hurme M | Int Immunopharmacol | 10.1016/s1567-5769(00)00018-7 | 2001 | Animals, Calcium/metabolism, Caseins/metabolism/*pharmacology, Cattle, Humans, Immunosuppressive Agents/*pharmacology, Interferon-gamma/biosynthesis, Interleukin-2/biosynthesis/genetics, Interleukin-4/biosynthesis, Lactobacillus/*physiology, Lymphocyte Activation/*drug effects, Protein Kinase C/physiology, RNA, Messenger/analysis, T-Lymphocytes/*drug effects/immunology | Metabolism |
Pathogenicity | 11375147 | Characterization of the properties of human- and dairy-derived probiotics for prevention of infectious diseases in fish. | Nikoskelainen S, Salminen S, Bylund G, Ouwehand AC | Appl Environ Microbiol | 10.1128/AEM.67.6.2430-2435.2001 | 2001 | Aeromonas/drug effects, Animals, Bacterial Adhesion, Bifidobacterium, Dairying/methods, Enterococcus faecium, Fish Diseases/*prevention & control, Flavobacterium/drug effects, Gram-Negative Bacterial Infections/prevention & control/*veterinary, *Gram-Positive Bacteria, Humans, *Lactic Acid, Lactobacillus, Probiotics/pharmacology/*therapeutic use, Vibrio/drug effects | |
Metabolism | 11425726 | Surface binding of aflatoxin B(1) by lactic acid bacteria. | Haskard CA, El-Nezami HS, Kankaanpaa PE, Salminen S, Ahokas JT | Appl Environ Microbiol | 10.1128/AEM.67.7.3086-3091.2001 | 2001 | Aflatoxin B1/*metabolism, Culture Media, Enzyme-Linked Immunosorbent Assay, Hot Temperature, Hydrogen-Ion Concentration, Lactobacillus/growth & development/*metabolism, Lactococcus/classification/growth & development/*metabolism, Protein Binding | Cultivation |
Pathogenicity | 11906339 | No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study. | Helin T, Haahtela S, Haahtela T | Allergy | 10.1034/j.1398-9995.2002.1s3299.x | 2002 | Administration, Oral, Adolescent, Adult, Betula/*immunology, Double-Blind Method, Female, Humans, Hypersensitivity/*therapy, *Lactobacillus, Male, Pollen/*immunology, Probiotics/*therapeutic use | |
Genetics | 12099838 | Structural studies of the exopolysaccharide produced by Lactobacillus rhamnosus strain GG (ATCC 53103). | Landersjo C, Yang Z, Huttunen E, Widmalm G | Biomacromolecules | 10.1021/bm020040q | 2002 | Carbohydrate Conformation, Carbohydrate Sequence, Lactobacillus/*chemistry, Molecular Sequence Data, Nuclear Magnetic Resonance, Biomolecular, Polysaccharides, Bacterial/*chemistry | |
Pathogenicity | 12446187 | Short-term consumption of probiotic-containing cheese and its effect on dental caries risk factors. | Ahola AJ, Yli-Knuuttila H, Suomalainen T, Poussa T, Ahlstrom A, Meurman JH, Korpela R | Arch Oral Biol | 10.1016/s0003-9969(02)00112-7 | 2002 | Adolescent, Adult, Cheese/*microbiology, Dental Caries/prevention & control, *Dental Caries Susceptibility, Double-Blind Method, Female, Humans, *Lactobacillus, Logistic Models, Male, Probiotics/*therapeutic use, Risk Factors, Saliva/metabolism/microbiology, Streptococcus mutans/isolation & purification, Yeasts/isolation & purification | Enzymology |
Pathogenicity | 12788576 | Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. | Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E | Lancet | 10.1016/S0140-6736(03)13490-3 | 2003 | Child, Preschool, Dermatitis, Atopic/diagnosis/*prevention & control, Follow-Up Studies, Humans, Infant, Infant, Newborn, *Lactobacillus, Probiotics/*therapeutic use, Randomized Controlled Trials as Topic, Skin Tests, Surveys and Questionnaires | |
14550670 | Immune enhancement in rainbow trout (Oncorhynchus mykiss) by potential probiotic bacteria (Lactobacillus rhamnosus). | Nikoskelainen S, Ouwehand AC, Bylund G, Salminen S, Lilius EM | Fish Shellfish Immunol | 10.1016/s1050-4648(03)00023-8 | 2003 | Analysis of Variance, Animal Feed, Animals, Dietary Supplements/*microbiology, Escherichia coli/pathogenicity, Immunoglobulins/blood, Lactobacillus/immunology/*physiology, Luminescent Measurements, Oncorhynchus mykiss/*immunology/*microbiology, *Probiotics | ||
Phylogeny | 16709533 | Probiotic lactobacilli and bacteraemia in Stockholm. | Sullivan A, Nord CE | Scand J Infect Dis | 10.1080/00365540500449826 | 2006 | Anti-Bacterial Agents/*therapeutic use, Bacteremia/drug therapy/epidemiology/*microbiology, Colony Count, Microbial, Gram-Positive Bacterial Infections/drug therapy/epidemiology/*microbiology, Humans, Immunocompromised Host, Lactobacillus/classification/*isolation & purification/pathogenicity, Lactobacillus acidophilus/classification/isolation & purification/pathogenicity, Lactobacillus rhamnosus/classification/isolation & purification/pathogenicity, Microbial Sensitivity Tests, *Probiotics/adverse effects, Sweden/epidemiology | Pathogenicity |
Phylogeny | 16877985 | Probiotic intervention in the first months of life: short-term effects on gastrointestinal symptoms and long-term effects on gut microbiota. | Rinne M, Kalliomaki M, Salminen S, Isolauri E | J Pediatr Gastroenterol Nutr | 10.1097/01.mpg.0000228106.91240.5b | 2006 | Adult, Bifidobacterium/growth & development/isolation & purification, Clostridium/growth & development/isolation & purification, Colony Count, Microbial, Crying, Diarrhea, Infantile/epidemiology/microbiology, Enterococcus/growth & development/isolation & purification, Feces/*microbiology, Female, Humans, In Situ Hybridization, Fluorescence, Infant, *Infant Nutritional Physiological Phenomena, Infant, Newborn, Lactobacillus rhamnosus/*growth & development/isolation & purification, Male, Pregnancy, Prenatal Care/*methods, *Probiotics, Species Specificity, Vomiting/epidemiology | Enzymology |
Pathogenicity | 17077076 | Intestinal colonisation, microbiota and future probiotics? | Salminen S, Benno Y, de Vos W | Asia Pac J Clin Nutr | 2006 | Bifidobacterium/growth & development/*physiology, Humans, Intestinal Diseases/*prevention & control, Intestines/*microbiology, Lactobacillus/growth & development/*physiology, *Probiotics/administration & dosage/therapeutic use | ||
Metabolism | 17292991 | Growth of probiotic bacteria and bifidobacteria in a soy yogurt formulation. | Farnworth ER, Mainville I, Desjardins MP, Gardner N, Fliss I, Champagne C | Int J Food Microbiol | 10.1016/j.ijfoodmicro.2006.12.015 | 2007 | Animals, Bifidobacterium/*growth & development/metabolism, Cattle, Chromatography, High Pressure Liquid, Colony Count, Microbial, Fermentation, Food Microbiology, Humans, Hydrogen-Ion Concentration, Lactobacillus/*growth & development/metabolism, Milk/microbiology, *Probiotics, Soy Foods/*microbiology, Yogurt/*microbiology | Biotechnology |
Metabolism | 17434999 | Functional analysis of D-alanylation of lipoteichoic acid in the probiotic strain Lactobacillus rhamnosus GG. | Perea Velez M, Verhoeven TL, Draing C, Von Aulock S, Pfitzenmaier M, Geyer A, Lambrichts I, Grangette C, Pot B, Vanderleyden J, De Keersmaecker SC | Appl Environ Microbiol | 10.1128/AEM.02083-06 | 2007 | Alanine/*metabolism, Anti-Bacterial Agents/pharmacology, Bacterial Adhesion/genetics, Bacterial Proteins/genetics, Bacteriolysis/genetics, Biofilms/growth & development, Cell Line, Cell Wall/chemistry/metabolism, Cytokines/immunology, DNA, Bacterial/chemistry/genetics, Epithelial Cells/immunology/microbiology, Gastric Juice/microbiology, Gene Deletion, Humans, Lactobacillus rhamnosus/drug effects/genetics/immunology/*metabolism, Lipopolysaccharides/chemistry/*metabolism, Magnetic Resonance Spectroscopy, Microbial Viability/genetics, Microscopy, Electron, Transmission, Molecular Sequence Data, Mutagenesis, Insertional, Nisin/pharmacology, Polymyxin B/pharmacology, Probiotics/chemistry/*metabolism, Sequence Analysis, DNA, Teichoic Acids/chemistry/*metabolism, Thiolester Hydrolases/genetics, beta-Defensins/immunology | Pathogenicity |
Metabolism | 17827316 | Impact of environmental and genetic factors on biofilm formation by the probiotic strain Lactobacillus rhamnosus GG. | Lebeer S, Verhoeven TL, Perea Velez M, Vanderleyden J, De Keersmaecker SC | Appl Environ Microbiol | 10.1128/AEM.01393-07 | 2007 | Bacterial Adhesion/*physiology, Bacterial Proteins/metabolism, Biofilms/*growth & development, Carbon-Sulfur Lyases/metabolism, Gene Expression Regulation, Bacterial, Genes, Bacterial, Lactobacillus rhamnosus/*genetics/physiology, Lipopolysaccharides/metabolism, Polysaccharides, Bacterial/metabolism, Probiotics, Teichoic Acids/metabolism | |
Phylogeny | 18326671 | Taxonomic and strain-specific identification of the probiotic strain Lactobacillus rhamnosus 35 within the Lactobacillus casei group. | Coudeyras S, Marchandin H, Fajon C, Forestier C | Appl Environ Microbiol | 10.1128/AEM.02286-07 | 2008 | Base Sequence, DNA Fingerprinting, DNA Primers/genetics, DNA, Bacterial/chemistry/*genetics, Electrophoresis, Gel, Pulsed-Field, Electrophoresis, Polyacrylamide Gel, Genes, rRNA, Hot Temperature, Lactobacillus rhamnosus/*classification/*genetics, Molecular Sequence Data, Nucleic Acid Denaturation, Nucleic Acid Hybridization, Phylogeny, Polymerase Chain Reaction/methods, *Probiotics, Ribotyping, Sensitivity and Specificity, Sequence Alignment, Sequence Analysis, DNA, Sequence Homology, Nucleic Acid | Enzymology |
Enzymology | 19465252 | Comparison of inactivation pathways of thermal or high pressure inactivated Lactobacillus rhamnosus ATCC 53103 by flow cytometry analysis. | Ananta E, Knorr D | Food Microbiol | 10.1016/j.fm.2009.01.008 | 2009 | Cell Separation, Colony Count, Microbial, *Flow Cytometry, Fluoresceins/pharmacokinetics, Fluorescent Dyes/*pharmacokinetics, Food Microbiology, Food Preservation/*methods, *Hot Temperature, *Hydrostatic Pressure, Kinetics, Lactobacillus rhamnosus/*growth & development, Probiotics, Propidium/pharmacokinetics | Biotechnology |
Genetics | 19820099 | Complete genome sequence of the probiotic Lactobacillus rhamnosus ATCC 53103. | Morita H, Toh H, Oshima K, Murakami M, Taylor TD, Igimi S, Hattori M | J Bacteriol | 10.1128/JB.01287-09 | 2009 | DNA, Bacterial/chemistry/*genetics, Gastrointestinal Tract/microbiology, *Genome, Bacterial, Humans, Lactobacillus rhamnosus/*genetics/isolation & purification, Molecular Sequence Data, Probiotics, *Sequence Analysis, DNA | Pathogenicity |
Pathogenicity | 20231842 | The impact of perinatal probiotic intervention on the development of overweight and obesity: follow-up study from birth to 10 years. | Luoto R, Kalliomaki M, Laitinen K, Isolauri E | Int J Obes (Lond) | 10.1038/ijo.2010.50 | 2010 | Age Factors, Birth Weight, Child, Preschool, Double-Blind Method, Female, Fetal Development, Finland/epidemiology, Follow-Up Studies, Humans, Infant, Infant, Newborn, *Lactobacillus rhamnosus, Male, Maternal Nutritional Physiological Phenomena, Obesity/epidemiology/physiopathology/*prevention & control, Pregnancy, Prenatal Care, Probiotics/*therapeutic use, Weight Gain/physiology | |
Metabolism | 20388096 | Lactobacillus rhamnosus GG influences polyamine metabolism in HGC-27 gastric cancer cell line: a strategy toward nutritional approach to chemoprevention of gastric cance. | Linsalata M, Cavallini A, Messa C, Orlando A, Refolo MG, Russo F | Curr Pharm Des | 10.2174/138161210790883598 | 2010 | Acetyltransferases/genetics/metabolism, Cell Line, Tumor, Cell Proliferation/*drug effects, Humans, Lactobacillus rhamnosus/*physiology, Ornithine Decarboxylase/genetics/metabolism, Polyamines/*metabolism, Probiotics/*pharmacology, RNA, Messenger/genetics/metabolism, Reverse Transcriptase Polymerase Chain Reaction, Stomach Neoplasms/*metabolism/microbiology/*prevention & control | Pathogenicity |
Cultivation | 20600855 | Evaluation of antimicrobial activity of probiotic bacteria against Salmonella enterica subsp. enterica serovar typhimurium 1344 in a common medium under different environmental conditions. | Marianelli C, Cifani N, Pasquali P | Res Microbiol | 10.1016/j.resmic.2010.06.007 | 2010 | Anaerobiosis, *Antibiosis, Bacillus/*physiology, Bacteriocins/metabolism, Culture Media, Hydrogen-Ion Concentration, Intestinal Mucosa/microbiology, Intestine, Small/microbiology, Lactobacillus reuteri/*physiology, Lactobacillus rhamnosus/*physiology, Oxidative Stress, *Probiotics, Salmonella typhimurium/*growth & development | Metabolism |
Pathogenicity | 20970896 | Impact of dietary counselling and probiotic intervention on maternal anthropometric measurements during and after pregnancy: a randomized placebo-controlled trial. | Ilmonen J, Isolauri E, Poussa T, Laitinen K | Clin Nutr | 10.1016/j.clnu.2010.09.009 | 2011 | Adiposity, Adult, Analysis of Variance, *Anthropometry, Bifidobacterium, Breast Feeding, *Counseling, *Diet, *Dietary Supplements, Double-Blind Method, Feeding Behavior, Female, Follow-Up Studies, Humans, Lactobacillus, Logistic Models, *Maternal Nutritional Physiological Phenomena, Pregnancy, Pregnancy Outcome, Pregnancy Trimester, First, Probiotics/*administration & dosage, Single-Blind Method | |
Enzymology | 21059281 | Manufacturing process influences properties of probiotic bacteria. | Grzeskowiak L, Isolauri E, Salminen S, Gueimonde M | Br J Nutr | 10.1017/S0007114510004496 | 2010 | *Bacterial Adhesion, Colon/*microbiology, DNA, Bacterial/analysis, Electrophoresis, Gel, Pulsed-Field, Humans, Hydrogen-Ion Concentration, Industry, Intestinal Mucosa/*microbiology, Lactobacillus rhamnosus/genetics/isolation & purification/*physiology, *Microbial Interactions, Probiotics/*analysis, Random Amplified Polymorphic DNA Technique, Species Specificity | Phylogeny |
Pathogenicity | 21121981 | Interaction of orally administered Lactobacillus rhamnosus GG with skin and gut microbiota and humoral immunity in infants with atopic dermatitis. | Nermes M, Kantele JM, Atosuo TJ, Salminen S, Isolauri E | Clin Exp Allergy | 10.1111/j.1365-2222.2010.03657.x | 2010 | Administration, Oral, B-Lymphocyte Subsets/immunology, Cell Separation, Dermatitis, Atopic/*immunology, Double-Blind Method, Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Humans, Immunity, Humoral/drug effects/immunology, Infant, Infant Formula/chemistry, Intestinal Mucosa/drug effects/*microbiology, Lactobacillus rhamnosus/*immunology, Polymerase Chain Reaction, Probiotics/*administration & dosage, Skin/drug effects/*microbiology | |
Pathogenicity | 21803698 | In vitro selection of antibiotic resistance in the probiotic strain Lactobacillus rhamnosus GG ATCC 53103. | Drago L, Rodighiero V, Mattina R, Toscano M, DE Vecchi E | J Chemother | 10.1179/joc.2011.23.4.211 | 2011 | Anti-Bacterial Agents/pharmacology, Dairy Products/microbiology, Drug Resistance, Microbial, Fluoroquinolones/pharmacology, Lactobacillus rhamnosus/*drug effects/genetics, Macrolides/pharmacology, Microbial Sensitivity Tests/methods, Mutation, *Probiotics | |
Biotechnology | 21819671 | Characterization of certain bacterial strains for potential use as starter or probiotic cultures in dairy products. | Monteagudo-Mera A, Caro I, Rodriguez-Aparicio LB, Rua J, Ferrero MA, Garcia-Armesto MR | J Food Prot | 10.4315/0362-028X.JFP-10-392 | 2011 | Animals, Cattle, Colony Count, Microbial, Dairy Products/*microbiology, Enterococcus faecalis/physiology, Fermentation, *Food Microbiology, Humans, Lactobacillus/physiology, Lactococcus/physiology, Leuconostoc/physiology, Milk/microbiology, *Probiotics, Sheep, Species Specificity | Pathogenicity |
22099374 | Stability of lactobacilli encapsulated in various microbial polymers. | Jimenez-Pranteda ML, Poncelet D, Nader-Macias ME, Arcos A, Aguilera M, Monteoliva-Sanchez M, Ramos-Cormenzana A | J Biosci Bioeng | 10.1016/j.jbiosc.2011.10.010 | 2011 | Bile/physiology, Biopolymers/chemistry, Capsules, Gastrointestinal Tract/physiology, Hydrogen-Ion Concentration, *Lactobacillus, Lactobacillus plantarum, Lactobacillus rhamnosus, Polysaccharides, Bacterial/*chemistry, Probiotics/*administration & dosage | ||
Genetics | 22328760 | Whole-genome shotgun sequencing of Lactobacillus rhamnosus MTCC 5462, a strain with probiotic potential. | Prajapati JB, Khedkar CD, Chitra J, Suja S, Mishra V, Sreeja V, Patel RK, Ahir VB, Bhatt VD, Sajnani MR, Jakhesara SJ, Koringa PG, Joshi CG | J Bacteriol | 10.1128/JB.06644-11 | 2012 | Cholesterol/metabolism, DNA, Bacterial/*chemistry/*genetics, Gastrointestinal Tract/*microbiology, *Genome, Bacterial, Humans, Immunologic Factors/pharmacology, Infant, Lactobacillus rhamnosus/*genetics/immunology/*isolation & purification/physiology, Molecular Sequence Data, *Probiotics, Sequence Analysis, DNA | Pathogenicity |
22440280 | Dietary addition of Lactobacillus rhamnosus GG impairs the health of Escherichia coli F4-challenged piglets. | Trevisi P, Casini L, Coloretti F, Mazzoni M, Merialdi G, Bosi P | Animal | 10.1017/S1751731111000462 | 2011 | |||
Metabolism | 22612915 | Characterization of a Panela cheese with added probiotics and fava bean starch. | Escobar MC, Van Tassell ML, Martinez-Bustos F, Singh M, Castano-Tostado E, Amaya-Llano SL, Miller MJ | J Dairy Sci | 10.3168/jds.2011-4655 | 2012 | Bifidobacterium/metabolism, *Cheese/standards, Food Microbiology/*methods, Food Technology/methods, Hydrolysis, Lactobacillus/metabolism, Probiotics/*metabolism, *Starch/metabolism, *Vicia faba/metabolism | Biotechnology |
Pathogenicity | 22816209 | Effect of LGG yoghurt on Streptococcus mutans and Lactobacillus spp. salivary counts in children. | Glavina D, Gorseta K, Skrinjaric I, Vranic DN, Mehulic K, Kozul K | Coll Antropol | 2012 | Child, Dental Caries/microbiology/*prevention & control, Dental Plaque/microbiology/prevention & control, Female, Humans, Lactobacillus rhamnosus/*growth & development, Male, Probiotics/*administration & dosage, Saliva/*microbiology, Streptococcus mutans/*growth & development, Yogurt/*microbiology | ||
Enzymology | 22955366 | Comparison of the kinetics of intestinal colonization by associating 5 probiotic bacteria assumed either in a microencapsulated or in a traditional, uncoated form. | Piano MD, Carmagnola S, Ballare M, Balzarini M, Montino F, Pagliarulo M, Anderloni A, Orsello M, Tari R, Sforza F, Mogna L, Mogna G | J Clin Gastroenterol | 10.1097/MCG.0b013e3182672796 | 2012 | Adult, Bifidobacterium/classification/*growth & development, Capsules/*administration & dosage, Colony Count, Microbial, Cross-Over Studies, Double-Blind Method, Feces/microbiology, Female, Gastrointestinal Transit, Humans, Intestines/*microbiology, Kinetics, Lactobacillus/classification/*growth & development, Lactobacillus acidophilus/growth & development, Lactobacillus rhamnosus/growth & development, Male, Middle Aged, Probiotics/*administration & dosage | Phylogeny |
Genetics | 23003331 | Evaluation of strain-specific primers for identification of Lactobacillus rhamnosus GG. | Endo A, Aakko J, Salminen S | FEMS Microbiol Lett | 10.1111/1574-6968.12015 | 2012 | Bacteriological Techniques/*methods, Bacteriophages/genetics, DNA Fingerprinting, DNA Primers/*genetics, DNA, Bacterial/chemistry/*genetics, Genotype, Lactobacillus rhamnosus/*classification/*genetics/isolation & purification, Molecular Sequence Data, Polymerase Chain Reaction/*methods, Sequence Analysis, DNA | Phylogeny |
Metabolism | 23332852 | Antimicrobial potential for the combination of bovine lactoferrin or its hydrolysate with lactoferrin-resistant probiotics against foodborne pathogens. | Chen PW, Jheng TT, Shyu CL, Mao FC | J Dairy Sci | 10.3168/jds.2012-6112 | 2013 | Animals, Anti-Infective Agents/administration & dosage/*therapeutic use, Bifidobacterium/metabolism, Cattle, Enterococcus faecalis/drug effects, Escherichia coli/drug effects, Lactobacillus/metabolism, Lactobacillus acidophilus/metabolism, Lactobacillus rhamnosus/metabolism, Lactoferrin/administration & dosage/drug effects/*therapeutic use, Pediococcus/metabolism, Probiotics/administration & dosage/*therapeutic use, Protein Hydrolysates, Salmonella typhimurium/drug effects | Pathogenicity |
23354703 | Genome instability in Lactobacillus rhamnosus GG. | Sybesma W, Molenaar D, van IJcken W, Venema K, Kort R | Appl Environ Microbiol | 10.1128/AEM.03566-12 | 2013 | DNA Transposable Elements, DNA, Bacterial/genetics, *Genomic Instability, Lactobacillus rhamnosus/*genetics, Polymerase Chain Reaction, Probiotics, Sequence Deletion | ||
Pathogenicity | 23886977 | The development of probiotic treatment in obesity: a review. | Mekkes MC, Weenen TC, Brummer RJ, Claassen E | Benef Microbes | 10.3920/BM2012.0069 | 2014 | Adipose Tissue/microbiology, Adiposity, Bifidobacterium/metabolism, Body Weight, Fatty Acids, Volatile/*biosynthesis, Gastrointestinal Tract/*microbiology, Humans, Inflammation/immunology/*microbiology, Lactobacillus/metabolism, Microbiota, Obesity/*therapy, Probiotics/*therapeutic use, Weight Loss | Metabolism |
Pathogenicity | 24118564 | Lactobacillus rhamnosus protects human colonic muscle from pathogen lipopolysaccharide-induced damage. | Ammoscato F, Scirocco A, Altomare A, Matarrese P, Petitta C, Ascione B, Caronna R, Guarino M, Marignani M, Cicala M, Chirletti P, Malorni W, Severi C | Neurogastroenterol Motil | 10.1111/nmo.12232 | 2013 | Cells, Cultured, Colon/drug effects/*microbiology, Gastrointestinal Motility, Humans, *Lactobacillus rhamnosus, Lipopolysaccharides/*toxicity, Muscle, Smooth/drug effects/*microbiology, Probiotics/*pharmacology | |
Pathogenicity | 24131826 | Prebiotic and probiotic supplementation prevents rhinovirus infections in preterm infants: a randomized, placebo-controlled trial. | Luoto R, Ruuskanen O, Waris M, Kalliomaki M, Salminen S, Isolauri E | J Allergy Clin Immunol | 10.1016/j.jaci.2013.08.020 | 2013 | DNA, Viral/analysis, Double-Blind Method, Female, Humans, Infant, Infant, Newborn, Infant, Premature, Male, Picornaviridae Infections/*prevention & control/virology, *Prebiotics, Probiotics/*therapeutic use, Respiratory Tract Diseases/*prevention & control/virology, Rhinovirus/*physiology, Viral Load | |
24281668 | Removal of cholera toxin from aqueous solution by probiotic bacteria. | Heikkila JE, Nybom SM, Salminen SJ, Meriluoto JA | Pharmaceuticals (Basel) | 10.3390/ph5060665 | 2012 | |||
Pathogenicity | 24501384 | Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus rhamnosus GG: a randomized, double-blind, placebo-controlled trial. | Sindhu KN, Sowmyanarayanan TV, Paul A, Babji S, Ajjampur SS, Priyadarshini S, Sarkar R, Balasubramanian KA, Wanke CA, Ward HD, Kang G | Clin Infect Dis | 10.1093/cid/ciu065 | 2014 | Antibodies, Protozoan/blood, Antibodies, Viral/blood, Child, Preschool, Cryptosporidiosis/*therapy, Double-Blind Method, Female, Gastroenteritis/*therapy, Gastrointestinal Tract/*physiology, Humans, Immunoglobulin A/blood, Immunoglobulin G/blood, India, Infant, Lactobacillus rhamnosus/*growth & development, Lactulose/analysis, Male, Mannitol/analysis, *Permeability, Placebos/administration & dosage, Probiotics/*administration & dosage, Rotavirus Infections/*therapy, Treatment Outcome, Urine/chemistry | |
Metabolism | 24632842 | Comparative genome analysis of Lactobacillus rhamnosus clinical isolates from initial stages of dental pulp infection: identification of a new exopolysaccharide cluster. | Nadkarni MA, Chen Z, Wilkins MR, Hunter N | PLoS One | 10.1371/journal.pone.0090643 | 2014 | Bacterial Adhesion/genetics/physiology, Bacterial Proteins/genetics/metabolism, Dental Pulp/*microbiology, Genomics/*methods, Humans, Lactobacillus rhamnosus/*genetics/*metabolism, Polysaccharides, Bacterial/genetics/*metabolism | Pathogenicity |
Pathogenicity | 25035097 | Lactobacillus rhamnosus GG suspected infection in a newborn with intrauterine growth restriction. | Sadowska-Krawczenko I, Paprzycka M, Korbal P, Wiatrzyk A, Krysztopa-Grzybowska K, Polak M, Czajka U, Lutynska A | Benef Microbes | 10.3920/BM2013.0074 | 2014 | Adolescent, Amplified Fragment Length Polymorphism Analysis, Anti-Bacterial Agents/*therapeutic use, Blood/*microbiology, C-Reactive Protein/analysis, DNA, Bacterial/chemistry/genetics, DNA, Ribosomal/chemistry/genetics, Female, Gram-Positive Bacterial Infections/*diagnosis/microbiology, Humans, Infant, Newborn, Lactobacillus rhamnosus/*isolation & purification, Male, Molecular Typing, Polymerase Chain Reaction, Probiotics/*administration & dosage/adverse effects, RNA, Ribosomal, 16S/genetics, Sequence Analysis, DNA | Phylogeny |
Metabolism | 25295259 | Cholesterol assimilation by Lactobacillus probiotic bacteria: an in vitro investigation. | Tomaro-Duchesneau C, Jones ML, Shah D, Jain P, Saha S, Prakash S | Biomed Res Int | 10.1155/2014/380316 | 2014 | Acyl Coenzyme A/antagonists & inhibitors, Amidohydrolases/*metabolism, Cardiovascular Diseases/drug therapy/metabolism/pathology, Cholesterol/*metabolism, Culture Media, Humans, In Vitro Techniques, Lactobacillus plantarum/*metabolism, Probiotics/*metabolism/therapeutic use | Cultivation |
Pathogenicity | 25438151 | No evidence of harms of probiotic Lactobacillus rhamnosus GG ATCC 53103 in healthy elderly-a phase I open label study to assess safety, tolerability and cytokine responses. | Hibberd PL, Kleimola L, Fiorino AM, Botelho C, Haverkamp M, Andreyeva I, Poutsiaka D, Fraser C, Solano-Aguilar G, Snydman DR | PLoS One | 10.1371/journal.pone.0113456 | 2014 | Aged, Aged, 80 and over, Cytokines/*blood, Drug Stability, Feces/microbiology, Female, *Healthy Volunteers, Humans, *Lactobacillus rhamnosus, Male, Patient Compliance, Probiotics/*adverse effects, *Safety | |
Pathogenicity | 25760553 | A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial. | Partty A, Kalliomaki M, Wacklin P, Salminen S, Isolauri E | Pediatr Res | 10.1038/pr.2015.51 | 2015 | Adolescent, Age Factors, Asperger Syndrome/*prevention & control, Attention Deficit Disorder with Hyperactivity/*prevention & control, Bifidobacterium/isolation & purification, Dietary Supplements, Feces/microbiology, Gastrointestinal Microbiome/*genetics, Humans, In Situ Hybridization, Fluorescence, Infant, Polymerase Chain Reaction, Probiotics/administration & dosage/*pharmacology | Enzymology |
Phylogeny | 25873374 | Functional dynamics of the gut microbiome in elderly people during probiotic consumption. | Eloe-Fadrosh EA, Brady A, Crabtree J, Drabek EF, Ma B, Mahurkar A, Ravel J, Haverkamp M, Fiorino AM, Botelho C, Andreyeva I, Hibberd PL, Fraser CM | mBio | 10.1128/mBio.00231-15 | 2015 | Aged, Aged, 80 and over, Cluster Analysis, DNA, Bacterial/chemistry/genetics, DNA, Ribosomal/chemistry/genetics, Female, *Gastrointestinal Microbiome, Gastrointestinal Tract/*microbiology, Gene Expression Profiling, Humans, Lactobacillus rhamnosus/*growth & development, Male, *Microbial Interactions, Molecular Sequence Data, *Phylogeny, Probiotics/*administration & dosage, RNA, Ribosomal, 16S/genetics, Sequence Analysis, DNA | Pathogenicity |
Genetics | 26048937 | Correlation of Lactobacillus rhamnosus Genotypes and Carbohydrate Utilization Signatures Determined by Phenotype Profiling. | Ceapa C, Lambert J, van Limpt K, Wels M, Smokvina T, Knol J, Kleerebezem M | Appl Environ Microbiol | 10.1128/AEM.00851-15 | 2015 | Amplified Fragment Length Polymorphism Analysis, *Bacterial Typing Techniques, Carbohydrate Metabolism, *DNA Fingerprinting, Dairy Products/*microbiology, Feces/*microbiology, Fermentation, Genetic Variation, Genome, Bacterial, *Genotype, Humans, Lactobacillus rhamnosus/*classification/genetics/isolation & purification/metabolism, Molecular Sequence Data, *Phenotype, Sequence Analysis, DNA | Phenotype |
Metabolism | 26092449 | An Exopolysaccharide-Deficient Mutant of Lactobacillus rhamnosus GG Efficiently Displays a Protective Llama Antibody Fragment against Rotavirus on Its Surface. | Alvarez B, Krogh-Andersen K, Tellgren-Roth C, Martinez N, Gunaydin G, Lin Y, Martin MC, Alvarez MA, Hammarstrom L, Marcotte H | Appl Environ Microbiol | 10.1128/AEM.00945-15 | 2015 | Animals, Bacterial Proteins/genetics/*metabolism, Disease Models, Animal, Female, Humans, Immunoglobulin Fragments/genetics/*metabolism, Lactobacillus rhamnosus/genetics/*metabolism, Male, Mice, Mice, Inbred BALB C, Molecular Sequence Data, Polysaccharides, Bacterial/*deficiency, Probiotics/administration & dosage, Rotavirus/*physiology, Rotavirus Infections/*microbiology/prevention & control/virology | Pathogenicity |
Pathogenicity | 26859761 | Transcriptomic Profile of Whole Blood Cells from Elderly Subjects Fed Probiotic Bacteria Lactobacillus rhamnosus GG ATCC 53103 (LGG) in a Phase I Open Label Study. | Solano-Aguilar G, Molokin A, Botelho C, Fiorino AM, Vinyard B, Li R, Chen C, Urban J Jr, Dawson H, Andreyeva I, Haverkamp M, Hibberd PL | PLoS One | 10.1371/journal.pone.0147426 | 2016 | Aged, Aged, 80 and over, Blood Cells/drug effects/*metabolism, Feces/microbiology, *Gene Expression Profiling, Healthy Volunteers, Humans, Lactobacillus rhamnosus/*physiology, Probiotics/adverse effects/*pharmacology, Sequence Analysis, RNA, Time Factors | Transcriptome |
Metabolism | 26913493 | Supplementation of xylitol-containing chewing gum with probiotics: a double blind, randomised pilot study focusing on saliva flow and saliva properties. | Gueimonde L, Vesterlund S, Garcia-Pola MJ, Gueimonde M, Soderling E, Salminen S | Food Funct | 10.1039/c5fo01497b | 2016 | Adult, Bifidobacterium/physiology, Chewing Gum/analysis/*microbiology, Double-Blind Method, Female, Food Additives/*analysis/metabolism, Humans, Lactobacillus/physiology, Male, Middle Aged, Probiotics/*analysis/metabolism, Saliva/chemistry/metabolism, Xylitol/*analysis/metabolism | Pathogenicity |
Metabolism | 26925601 | Immunological mechanisms involved in probiotic-mediated protection against Citrobacter rodentium-induced colitis. | Jiang Y, Yang G, Meng F, Yang W, Hu J, Ye L, Shi C, Wang C | Benef Microbes | 10.3920/BM2015.0119 | 2016 | Citrobacter rodentium/*pathogenicity, Colitis/*pathology, Cytokines/metabolism, Dendritic Cells/immunology, Immune Tolerance, Immunologic Factors/*administration & dosage, Lactobacillus/*immunology, Lymph Nodes/immunology, Probiotics/*administration & dosage, Spleen/immunology, T-Lymphocytes, Regulatory/immunology | |
Metabolism | 27102127 | Characterization of biosurfactants produced by Lactobacillus spp. and their activity against oral streptococci biofilm. | Ciandrini E, Campana R, Casettari L, Perinelli DR, Fagioli L, Manti A, Palmieri GF, Papa S, Baffone W | Appl Microbiol Biotechnol | 10.1007/s00253-016-7531-7 | 2016 | Anti-Bacterial Agents/*metabolism, Bacterial Adhesion/drug effects, Biofilms/*growth & development, Lactobacillus acidophilus/*metabolism, Lactobacillus paracasei/*metabolism, Lactobacillus reuteri/*metabolism, Lactobacillus rhamnosus/*metabolism, Microbial Sensitivity Tests, Streptococcus mutans/drug effects/*growth & development, Streptococcus oralis/drug effects/*growth & development, Surface Tension/drug effects, Surface-Active Agents/*metabolism/pharmacology, Titanium | Pathogenicity |
27702519 | An improved pH-responsive carrier based on EDTA-Ca-alginate for oral delivery of Lactobacillus rhamnosus ATCC 53103. | Zheng H, Gao M, Ren Y, Lou R, Xie H, Yu W, Liu X, Ma X | Carbohydr Polym | 10.1016/j.carbpol.2016.08.096 | 2016 | Alginates/*chemistry, Calcium/*chemistry, Edetic Acid/*chemistry, Glucuronic Acid/chemistry, Hexuronic Acids/chemistry, Hydrogels, Hydrogen-Ion Concentration, *Lactobacillus rhamnosus, Probiotics/*administration & dosage | ||
Metabolism | 27714445 | Human milk and mucosal lacto- and galacto-N-biose synthesis by transgalactosylation and their prebiotic potential in Lactobacillus species. | Bidart GN, Rodriguez-Diaz J, Palomino-Schatzlein M, Monedero V, Yebra MJ | Appl Microbiol Biotechnol | 10.1007/s00253-016-7882-0 | 2016 | Acetylgalactosamine/metabolism, Acetylglucosamine/metabolism, Disaccharides/chemistry/*metabolism, Glycoside Hydrolases/*metabolism, Glycosylation, Intestinal Mucosa/*metabolism, Kinetics, Lactobacillus/enzymology/*metabolism, Magnetic Resonance Spectroscopy, Milk, Human/*metabolism, Nucleic Acid Hybridization, *Prebiotics | Enzymology |
Pathogenicity | 27741159 | Protective Role of Postbiotic Mediators Secreted by Lactobacillus rhamnosus GG Versus Lipopolysaccharide-induced Damage in Human Colonic Smooth Muscle Cells. | Cicenia A, Santangelo F, Gambardella L, Pallotta L, Iebba V, Scirocco A, Marignani M, Tellan G, Carabotti M, Corazziari ES, Schippa S, Severi C | J Clin Gastroenterol | 10.1097/MCG.0000000000000681 | 2016 | Anti-Bacterial Agents/biosynthesis/*metabolism, Bacteriocins/biosynthesis/*metabolism, Colon/cytology/microbiology, Endotoxins/*toxicity, Humans, Lactobacillus rhamnosus/*physiology, Myocytes, Smooth Muscle/drug effects/*microbiology, Probiotics/metabolism/therapeutic use | Metabolism |
Stress | 28193570 | Live and heat-killed Lactobacillus spp. interfere with Streptococcus mutans and Streptococcus oralis during biofilm development on titanium surface. | Ciandrini E, Campana R, Baffone W | Arch Oral Biol | 10.1016/j.archoralbio.2017.02.004 | 2017 | *Antibiosis, Bacterial Adhesion, Biofilms/*growth & development, Hot Temperature, Lactobacillus/*physiology, Streptococcus mutans/*growth & development, Streptococcus oralis/*growth & development, Surface Properties, Titanium/*chemistry | |
Metabolism | 28244112 | In vitro fermentation of oat beta-glucan and hydrolysates by fecal microbiota and selected probiotic strains. | Dong JL, Yu X, Dong LE, Shen RL | J Sci Food Agric | 10.1002/jsfa.8292 | 2017 | Animals, Avena/metabolism/*microbiology, Fatty Acids, Volatile/analysis/metabolism, Feces/*microbiology, Fermentation, Hydrolysis, Lactobacillus/classification/isolation & purification/*metabolism, Male, *Microbiota, Probiotics/analysis/*metabolism, Rats, Rats, Sprague-Dawley, beta-Glucans/*metabolism | Phylogeny |
28411984 | Capability of exopolysaccharide-producing Lactobacillus paraplantarum BGCG11 and its non-producing isogenic strain NB1, to counteract the effect of enteropathogens upon the epithelial cell line HT29-MTX. | Zivkovic M, Hidalgo-Cantabrana C, Kojic M, Gueimonde M, Golic N, Ruas-Madiedo P | Food Res Int | 10.1016/j.foodres.2015.05.012 | 2015 | |||
28579977 | In silico Prediction, in vitro Antibacterial Spectrum, and Physicochemical Properties of a Putative Bacteriocin Produced by Lactobacillus rhamnosus Strain L156.4. | Oliveira LC, Silveira AMM, Monteiro AS, Dos Santos VL, Nicoli JR, Azevedo VAC, Soares SC, Dias-Souza MV, Nardi RMD | Front Microbiol | 10.3389/fmicb.2017.00876 | 2017 | |||
Metabolism | 28843807 | A comparative study of procedures for binding of aflatoxin M1 to Lactobacillus rhamnosus GG. | Assaf JC, Atoui A, Khoury AE, Chokr A, Louka N | Braz J Microbiol | 10.1016/j.bjm.2017.05.003 | 2017 | Aflatoxin M1/*chemistry/metabolism, Animals, Culture Media/chemistry, Lactobacillus rhamnosus/*chemistry/metabolism | Cultivation |
Pathogenicity | 28947466 | Randomised controlled trial of Lactobacillus rhamnosus (LGG) versus placebo in children presenting to the emergency department with acute gastroenteritis: the PECARN probiotic study protocol. | Schnadower D, Tarr PI, Casper TC, Gorelick MH, Dean MJ, O'Connell KJ, Mahajan P, Chun TH, Bhatt SR, Roskind CG, Powell EC, Rogers AJ, Vance C, Sapien RE, Gao F, Freedman SB | BMJ Open | 10.1136/bmjopen-2017-018115 | 2017 | Acute Disease, Child, Child, Preschool, Clinical Protocols, Double-Blind Method, Emergency Service, Hospital, Female, Gastroenteritis/*therapy, Humans, Infant, Intention to Treat Analysis, *Lactobacillus rhamnosus, Male, Probiotics/*administration & dosage/adverse effects, Severity of Illness Index | |
Pathogenicity | 29063625 | Effect of phenolic compounds on the growth of selected probiotic and pathogenic bacteria. | Pacheco-Ordaz R, Wall-Medrano A, Goni MG, Ramos-Clamont-Montfort G, Ayala-Zavala JF, Gonzalez-Aguilar GA | Lett Appl Microbiol | 10.1111/lam.12814 | 2018 | Anti-Bacterial Agents/*pharmacology, Escherichia coli/*drug effects/growth & development, Humans, Hydroxybenzoates/pharmacology, Lactobacillus/*drug effects/growth & development, Phenols/chemistry/*pharmacology, Probiotics/*analysis, Salmonella typhimurium/*drug effects/growth & development | |
Pathogenicity | 29402455 | Routine Supplementation of Lactobacillus rhamnosus GG and Risk of Necrotizing Enterocolitis in Very Low Birth Weight Infants. | Kane AF, Bhatia AD, Denning PW, Shane AL, Patel RM | J Pediatr | 10.1016/j.jpeds.2017.11.055 | 2018 | Enterocolitis, Necrotizing/epidemiology/*prevention & control, Female, Gestational Age, Humans, Infant, Infant, Newborn, Infant, Very Low Birth Weight, *Lactobacillus rhamnosus, Logistic Models, Male, Probiotics/*administration & dosage/adverse effects, Retrospective Studies, Risk Factors | |
Pathogenicity | 29455334 | Septicemia from Lactobacillus rhamnosus GG, from a Probiotic Enriched Yogurt, in a Patient with Autologous Stem Cell Transplantation. | Koyama S, Fujita H, Shimosato T, Kamijo A, Ishiyama Y, Yamamoto E, Ishii Y, Hattori Y, Hagihara M, Yamazaki E, Tomita N, Nakajima H | Probiotics Antimicrob Proteins | 10.1007/s12602-018-9399-6 | 2019 | Hematopoietic Stem Cell Transplantation, Humans, Lactobacillus rhamnosus/growth & development/*physiology, Leukemia/*therapy, Male, Middle Aged, Probiotics/*adverse effects/analysis, Sepsis/*etiology/microbiology, Transplantation, Autologous, Yogurt/*adverse effects/microbiology | |
Phylogeny | 29599835 | Antibacterial effects of bacteriocins isolated from Lactobacillus rhamnosus (ATCC 53103) in a rabbit model of knee implant infection. | Zhou B, Zhang D | Exp Ther Med | 10.3892/etm.2018.5790 | 2018 | ||
Pathogenicity | 29762266 | Flow Cytometry: Evolution of Microbiological Methods for Probiotics Enumeration. | Pane M, Allesina S, Amoruso A, Nicola S, Deidda F, Mogna L | J Clin Gastroenterol | 10.1097/MCG.0000000000001057 | 2018 | Animals, Bacterial Load/*methods, Flow Cytometry/*methods, Food Microbiology/*methods, Humans, Lactobacillus rhamnosus/*growth & development, Milk/microbiology, Probiotics/*analysis, Reproducibility of Results | Biotechnology |
Cultivation | 30086200 | Lactobacillus rhamnosus LRB mediated inhibition of oral streptococci. | Biswas S, Turner L, Biswas I | Mol Oral Microbiol | 10.1111/omi.12242 | 2018 | *Antibiosis, Child, Culture Media, Conditioned/chemistry, Humans, Lactic Acid/*metabolism, Lactobacillus rhamnosus/genetics/isolation & purification/*physiology, *Probiotics, Streptococcus/*growth & development | Pathogenicity |
Phylogeny | 30319846 | Evaluation of probiotic potential and anti-hyperglycemic properties of a novel Lactobacillus strain isolated from water kefir grains. | Koh WY, Utra U, Ahmad R, Rather IA, Park YH | Food Sci Biotechnol | 10.1007/s10068-018-0360-y | 2018 | ||
30666850 | Oral administration of Lactobacillus rhamnosus GG to newborn piglets augments gut barrier function in pre-weaning piglets. | Wang Y, Gong L, Wu YP, Cui ZW, Wang YQ, Huang Y, Zhang XP, Li WF | J Zhejiang Univ Sci B | 10.1631/jzus.B1800022 | 2019 | Administration, Oral, Animals, Animals, Newborn, Cytokines/genetics, Female, Gastrointestinal Microbiome, Immunity, Innate, Intestinal Mucosa/*immunology, *Lactobacillus rhamnosus, Male, Probiotics/*administration & dosage, Signal Transduction, Swine, Weaning | ||
Biotechnology | 30884731 | Matrix-wise evaluation of in vivo and in vitro efficiencies of L. rhamnosus GG-fortified beverages. | Sireswar S, Dey G | Food Res Int | 10.1016/j.foodres.2018.10.077 | 2018 | Animals, Beverages/analysis/*microbiology, Disease Models, Animal, Enterocolitis/pathology/prevention & control, Food Microbiology, Fruit/*chemistry, Gastrointestinal Microbiome/physiology, Gastrointestinal Tract/microbiology, Hippophae/*chemistry, Hydroxybenzoates/analysis, Lactobacillus rhamnosus/*physiology, Malus/*chemistry, Probiotics/*therapeutic use, Quercetin/analogs & derivatives/analysis, Rheology, Shear Strength, Zebrafish | |
Pathogenicity | 31965835 | Probiotics exert reciprocal effects on autophagy and interleukin-1beta expression in Salmonella-infected intestinal epithelial cells via autophagy-related 16L1 protein. | Lai WT, Huang FC | Benef Microbes | 10.3920/BM2019.0046 | 2019 | Autophagy/*drug effects, Autophagy-Related Proteins/genetics/*metabolism, Bifidobacterium longum/physiology, Caco-2 Cells, Colony Count, Microbial, Gene Expression/drug effects, Gene Expression Regulation/drug effects, Gene Silencing, Humans, Interleukin-1beta/*genetics, Intestinal Mucosa/*drug effects/metabolism/microbiology/pathology, Lactobacillus rhamnosus/physiology, Microtubule-Associated Proteins/metabolism, Nod2 Signaling Adaptor Protein/genetics/metabolism, Probiotics/*pharmacology, Receptors, Calcitriol/genetics, Salmonella typhimurium/*drug effects/growth & development/metabolism | Metabolism |
Pathogenicity | 31970371 | Effects of regular and decaffeinated roasted coffee (Coffea arabica and Coffea canephora) extracts and bioactive compounds on in vitro probiotic bacterial growth. | Sales AL, dePaula J, Mellinger Silva C, Cruz A, Lemos Miguel MA, Farah A | Food Funct | 10.1039/c9fo02589h | 2020 | Caffeine/*pharmacology, *Coffea, Coffee/*chemistry, Escherichia coli/*drug effects, Food Handling, Humans, Lactobacillus/*drug effects, Plant Extracts/*pharmacology, *Probiotics | |
Pathogenicity | 32154524 | Adhesion and anti-inflammatory potential of Lactobacillus rhamnosus GG in a sea buckthorn based beverage matrix. | Sireswar S, Biswas S, Dey G | Food Funct | 10.1039/c9fo02249j | 2020 | Animals, *Beverages, *Cell Adhesion, Cell Survival, HCT116 Cells, *Hippophae, Humans, Inflammation/chemically induced/drug therapy, *Lactobacillus rhamnosus, Lipopolysaccharides/toxicity, Zebrafish | |
Metabolism | 32169430 | Lactococcus lactis Subspecies cremoris Elicits Protection Against Metabolic Changes Induced by a Western-Style Diet. | Naudin CR, Maner-Smith K, Owens JA, Wynn GM, Robinson BS, Matthews JD, Reedy AR, Luo L, Wolfarth AA, Darby TM, Ortlund EA, Jones RM | Gastroenterology | 10.1053/j.gastro.2020.03.010 | 2020 | Animals, Cholesterol/blood/metabolism, Diet, Western/*adverse effects, Disease Models, Animal, Dyslipidemias/blood/diagnosis/metabolism/*prevention & control, Female, Humans, Insulin Resistance, *Lactococcus, Liver/pathology, Mice, Non-alcoholic Fatty Liver Disease/blood/metabolism/pathology/*prevention & control, Probiotics/*administration & dosage, Weight Gain | Pathogenicity |
32256407 | A Pilot Randomized Control Trial With the Probiotic Strain Lactobacillus rhamnosus GG (LGG) in ADHD: Children and Adolescents Report Better Health-Related Quality of Life. | Kumperscak HG, Gricar A, Ulen I, Micetic-Turk D | Front Psychiatry | 10.3389/fpsyt.2020.00181 | 2020 | |||
Pathogenicity | 32307246 | Lactobacillus rhamnosus sepsis associated with probiotic therapy in an extremely preterm infant: Pathogenesis and a review for clinicians. | Chiang MC, Chen CL, Feng Y, Chen CC, Lien R, Chiu CH | J Microbiol Immunol Infect | 10.1016/j.jmii.2020.03.029 | 2020 | Administration, Oral, Anti-Bacterial Agents/therapeutic use, Biofilms/growth & development, Enterocolitis, Necrotizing/prevention & control, Humans, Infant, Extremely Premature, Infant, Newborn, Lactobacillus rhamnosus/drug effects/genetics/isolation & purification/*pathogenicity, Probiotics/administration & dosage/*adverse effects, Sepsis/diagnosis/drug therapy/*etiology | Enzymology |
Pathogenicity | 32332478 | Probiotics and Preterm Infants: A Position Paper by the European Society for Paediatric Gastroenterology Hepatology and Nutrition Committee on Nutrition and the European Society for Paediatric Gastroenterology Hepatology and Nutrition Working Group for Probiotics and Prebiotics. | van den Akker CHP, van Goudoever JB, Shamir R, Domellof M, Embleton ND, Hojsak I, Lapillonne A, Mihatsch WA, Berni Canani R, Bronsky J, Campoy C, Fewtrell MS, Fidler Mis N, Guarino A, Hulst JM, Indrio F, Kolacek S, Orel R, Vandenplas Y, Weizman Z, Szajewska H | J Pediatr Gastroenterol Nutr | 10.1097/MPG.0000000000002655 | 2020 | Child, *Enterocolitis, Necrotizing/epidemiology/prevention & control, *Gastroenterology, Humans, Infant, Infant, Newborn, Infant, Premature, Prebiotics, *Probiotics | |
Pathogenicity | 32512895 | Anti-Inflammatory and Gut Microbiota Modulatory Effect of Lactobacillus rhamnosus Strain LDTM 7511 in a Dextran Sulfate Sodium-Induced Colitis Murine Model. | Yeo S, Park H, Seo E, Kim J, Kim BK, Choi IS, Huh CS | Microorganisms | 10.3390/microorganisms8060845 | 2020 | ||
Pathogenicity | 32517123 | Lactobacillus rhamnosus GG (ATCC 53103) for the Management of Infantile Colic: A Randomized Controlled Trial. | Savino F, Montanari P, Galliano I, Dapra V, Bergallo M | Nutrients | 10.3390/nu12061693 | 2020 | Adult, Animals, *Breast Feeding, Colic/*therapy, *Diet, *Dietary Supplements, Feces/chemistry, Female, *Gastrointestinal Microbiome, Humans, Infant, Infant, Newborn, *Lactobacillus rhamnosus, Leukocyte L1 Antigen Complex/metabolism, Male, Milk/adverse effects, Probiotics/*administration & dosage, Treatment Outcome, Young Adult | Metabolism |
32621828 | New insights in enumeration methodologies of probiotic cells in finished products. | Foglia C, Allesina S, Amoruso A, De Prisco A, Pane M | J Microbiol Methods | 10.1016/j.mimet.2020.105993 | 2020 | Colony Count, Microbial/*methods, Flow Cytometry/*methods, Lactobacillus rhamnosus/*growth & development, Microbial Viability, Probiotics/*analysis | ||
Pathogenicity | 32759442 | Study of anti-virus actions of metabolites of lactobacteria. | Kalinichenko SV, Melentyevsmall a, Cyrillic KV, Manee H, Dubinina NV, Zvereva NV, Toryanik II, Popova NG, Pakhomov OV | Wiad Lek | 2020 | Antiviral Agents, *Enterovirus Infections, Feces, Humans, *Lactobacillus rhamnosus, *Probiotics | ||
32793131 | First Evidence of Acyl-Hydrolase/Lipase Activity From Human Probiotic Bacteria: Lactobacillus rhamnosus GG and Bifidobacterium longum NCC 2705. | Manasian P, Bustos AS, Palsson B, Hakansson A, Penarrieta JM, Nilsson L, Linares-Pasten JA | Front Microbiol | 10.3389/fmicb.2020.01534 | 2020 | |||
32847138 | Anti-Biofilm Properties of Saccharomyces cerevisiae CNCM I-3856 and Lacticaseibacillus rhamnosus ATCC 53103 Probiotics against G. vaginalis. | Sabbatini S, Monari C, Ballet N, Decherf AC, Bozza S, Camilloni B, Perito S, Vecchiarelli A | Microorganisms | 10.3390/microorganisms8091294 | 2020 | |||
32978757 | Development and Comparative Evaluation of a Novel Fermented Juice Mixture with Probiotic Strains of Lactic Acid Bacteria and Bifidobacteria. | Guney D, Gungormusler M | Probiotics Antimicrob Proteins | 10.1007/s12602-020-09710-2 | 2020 | *Bifidobacterium animalis, Fermented Beverages/*microbiology, Fruit and Vegetable Juices/*microbiology, *Lactobacillales, *Probiotics | ||
33247747 | A Validated Real-Time PCR Method for the Specific Identification of Probiotic Strain Lactobacillus rhamnosus GG (ATCC 53103). | Shehata HR, Newmaster SG | J AOAC Int | 10.1093/jaoacint/qsaa063 | 2020 | *Lactobacillus rhamnosus/genetics, *Probiotics, *Real-Time Polymerase Chain Reaction, Reproducibility of Results | ||
33391230 | Probiotic Lactobacillus rhamnosus GG Promotes Mouse Gut Microbiota Diversity and T Cell Differentiation. | Shi CW, Cheng MY, Yang X, Lu YY, Yin HD, Zeng Y, Wang RY, Jiang YL, Yang WT, Wang JZ, Zhao DD, Huang HB, Ye LP, Cao X, Yang GL, Wang CF | Front Microbiol | 10.3389/fmicb.2020.607735 | 2020 | |||
Metabolism | 33450655 | Specific Lactobacillus probiotic strains decrease transepithelial glucose transport through GLUT2 downregulation in intestinal epithelial cell models. | Primec M, Skorjanc D, Langerholc T, Micetic-Turk D, Gorenjak M | Nutr Res | 10.1016/j.nutres.2020.11.008 | 2020 | Animals, Biological Transport, Caco-2 Cells, Cell Line, Down-Regulation, Enterocytes/*metabolism, Epithelial Cells/metabolism, Glucose/*metabolism, Glucose Transporter Type 2/*genetics/metabolism, Humans, Intestinal Mucosa/cytology/*metabolism, *Lactobacillus, *Probiotics, Sodium-Glucose Transporter 1/genetics/metabolism, Swine, Transcription, Genetic | Pathogenicity |
33678902 | Biodiversity of meatborne Listeria spp. in Himachal Pradesh and their interaction with indigenous probiotics. | Sharma A, Kanwar SS, Thakur SD | J Food Sci Technol | 10.1007/s13197-020-04854-z | 2020 | |||
33711368 | Microencapsulation of Lactobacillus casei and Lactobacillus rhamnosus in pectin and pectin-inulin microgel particles: Effect on bacterial survival under storage conditions. | Tarifa MC, Piqueras CM, Genovese DB, Brugnoni LI | Int J Biol Macromol | 10.1016/j.ijbiomac.2021.03.038 | 2021 | Capsules/*chemistry, Inulin/*chemistry, Lactobacillus casei/*growth & development, Lactobacillus rhamnosus/*growth & development, Microbial Viability, Microgels/*chemistry, Pectins/*chemistry | ||
Metabolism | 33932824 | Probiotics Lactobacillus rhamnosus GG ATCC53103 and Lactobacillus plantarum JL01 induce cytokine alterations by the production of TCDA, DHA, and succinic and palmitic acids, and enhance immunity of weaned piglets. | Geng T, He F, Su S, Sun K, Zhao L, Zhao Y, Bao N, Pan L, Sun H | Res Vet Sci | 10.1016/j.rvsc.2021.04.011 | 2021 | Animals, Cytokines/genetics/*metabolism, Docosahexaenoic Acids/metabolism, Gene Expression Regulation/drug effects, Intestinal Mucosa/metabolism, *Lactobacillus plantarum, *Lactobacillus rhamnosus, Palmitic Acids/metabolism, *Probiotics, Random Allocation, Succinic Acid/metabolism, Swine/*metabolism, Taurochenodeoxycholic Acid/metabolism, Weaning | Biotechnology |
Enzymology | 34591288 | Enumeration of Probiotic Strain Lacticaseibacillus rhamnosus GG (ATCC 53103) Using Viability Real-time PCR. | Shehata HR, Newmaster SG | Probiotics Antimicrob Proteins | 10.1007/s12602-021-09849-6 | 2021 | Lactobacillus rhamnosus/*isolation & purification, *Probiotics, Real-Time Polymerase Chain Reaction | Phylogeny |
Pathogenicity | 34600663 | Influence of fruit-based beverages on efficacy of Lacticaseibacillus rhamnosus GG (Lactobacillus rhamnosus GG) against DSS-induced intestinal inflammation. | Sireswar S, Dey G, Biswas S | Food Res Int | 10.1016/j.foodres.2021.110661 | 2021 | Animals, Beverages, Fruit, Inflammation, *Lactobacillus rhamnosus, Zebrafish | |
Stress | 34899662 | Ribosome Profiling and RNA Sequencing Reveal Genome-Wide Cellular Translation and Transcription Regulation Under Osmotic Stress in Lactobacillus rhamnosus ATCC 53103. | Fan X, Bao T, Yi H, Zhang Z, Zhang K, Liu X, Lin X, Zhang Z, Feng Z | Front Microbiol | 10.3389/fmicb.2021.781454 | 2021 | ||
Pathogenicity | 35123664 | Probiotic peanut oral immunotherapy versus oral immunotherapy and placebo in children with peanut allergy in Australia (PPOIT-003): a multicentre, randomised, phase 2b trial. | Loke P, Orsini F, Lozinsky AC, Gold M, O'Sullivan MD, Quinn P, Lloyd M, Ashley SE, Pitkin S, Axelrad C, Metcalfe JR, Su EL, Tey D, Robinson MN, Allen KJ, Prescott SL, Galvin AD, Tang MLK | Lancet Child Adolesc Health | 10.1016/S2352-4642(22)00006-2 | 2022 | Administration, Oral, Allergens/*administration & dosage, Arachis/*immunology, Australia, Child, Child, Preschool, Desensitization, Immunologic/*methods, Dietary Proteins/administration & dosage, Double-Blind Method, Female, Humans, Immunologic Factors/*administration & dosage, Infant, Lactobacillus rhamnosus/*immunology, Male, Peanut Hypersensitivity/*therapy, Probiotics/*administration & dosage, Quality of Life, Tertiary Care Centers, Treatment Outcome | |
Pathogenicity | 35334835 | Lactobacilli Infection Case Reports in the Last Three Years and Safety Implications. | Rossi F, Amadoro C, Gasperi M, Colavita G | Nutrients | 10.3390/nu14061178 | 2022 | Humans, Lactobacillus/genetics, *Lactobacillus rhamnosus/genetics, *Microbiota, *Probiotics | |
35549737 | Improvement of probiotic viability through the design of novel biomaterials using coffee pulp wastes and Lactobacillus rhamnosus. | Rosales Delgado S, Alzate Arbelaez AF, Zapata Acosta K, Cortes FB, Rojano BA | Food Sci Technol Int | 10.1177/10820132221100683 | 2022 | |||
Stress | 35626981 | Ribosome Profiling Reveals Genome-Wide Cellular Translational Regulation in Lacticaseibacillus rhamnosus ATCC 53103 under Acid Stress. | Fan X, Zhang K, Zhang Z, Zhang Z, Lin X, Liu X, Feng Z, Yi H | Foods | 10.3390/foods11101411 | 2022 | ||
35812820 | Rationale, design, and methods: A randomized placebo-controlled trial of an immunomodulatory probiotic intervention for Veterans with PTSD. | Brenner LA, Stearns-Yoder KA, Stamper CE, Hoisington AJ, Brostow DP, Hoffmire CA, Forster JE, Donovan ML, Ryan AT, Postolache TT, Lowry CA | Contemp Clin Trials Commun | 10.1016/j.conctc.2022.100960 | 2022 | |||
Phylogeny | 36141000 | Anti-Biofilm Activity of Cell Free Supernatants of Selected Lactic Acid Bacteria against Listeria monocytogenes Isolated from Avocado and Cucumber Fruits, and from an Avocado Processing Plant. | Masebe RD, Thantsha MS | Foods | 10.3390/foods11182872 | 2022 | ||
Pathogenicity | 36401067 | In vitro characterization of lactic acid bacterial strains isolated from fermented foods with anti-inflammatory and dipeptidyl peptidase-IV inhibition potential. | Bhatia R, Singh S, Maurya R, Bhadada SK, Bishnoi M, Chopra K, Joshi SR, Kondepudi KK | Braz J Microbiol | 10.1007/s42770-022-00872-5 | 2022 | ||
36517529 | In vitro assessment of probiotic attributes for strains contained in commercial formulations. | Mazzantini D, Calvigioni M, Celandroni F, Lupetti A, Ghelardi E | Sci Rep | 10.1038/s41598-022-25688-z | 2022 |
Reference
@id | authors | title | doi/url | catalogue | journal | pubmed |
---|---|---|---|---|---|---|
20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M. | List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ | 10.1099/ijsem.0.004332 | |||
52036 | Curators of the CCUG | https://www.ccug.se/strain?id=34291 | Culture Collection University of Gothenburg (CCUG) (CCUG 34291) | |||
66792 | Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann | Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) | https://diaspora-project.de/progress.html#genomes | |||
66794 | Antje Chang, Lisa Jeske, Sandra Ulbrich, Julia Hofmann, Julia Koblitz, Ida Schomburg, Meina Neumann-Schaal, Dieter Jahn, Dietmar Schomburg | BRENDA, the ELIXIR core data resource in 2021: new developments and updates | 10.1093/nar/gkaa1025 | Nucleic Acids Res. 49: D498-D508 2020 | 33211880 | |
68371 | Automatically annotated from API 50CH acid | |||||
68381 | Automatically annotated from API rID32STR | |||||
69480 | Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann | Predictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) | https://diaspora-project.de/progress.html#genomes | |||
69481 | Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. Münch | Predictions based on the model GenomeNet Sporulation v. 1 | 10.21203/rs.3.rs-2527258/v1 | |||
102489 | Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J. | StrainInfo: A central database for resolving microbial strain identifiers | 10.60712/SI-ID8915.1 |